Keywords: hana, biosci, in-licenses, menadione, biosciences, biopharmaceutical, company

Hana Biosci in-licenses menadione

Article | 23 October 2006

Print This

Hana Biosciences, a US biopharmaceutical company focused on advancing cancer care, reports that it has acquired exclusive rights to develop ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in